Glutamate Dehydrogenase–Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction

Dopamine neuron dependent behaviors mediated by glutamate cotransmission

(2017) Susana Mingote et al.   eLife

Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis

(2016) Paul Allen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Age-Dependent Specific Changes in Area CA2 of the Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion Syndrome

(2016) Rebecca A. Piskorowski et al.   NEURON

Using human brain imaging studies as a guide toward animal models of schizophrenia

(2016) S.S. Bolkan et al.   NEUROSCIENCE

Dorsal hippocampus infusions of CNQX into the dentate gyrus disrupt expression of trace fear conditioning

(2015) Jamie L. Pierson et al.   HIPPOCAMPUS

Intrinsic Hippocampal Activity as a Biomarker for Cognition and Symptoms in Schizophrenia

(2014) Jason R. Tregellas et al.   AMERICAN JOURNAL OF PSYCHIATRY

The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies

(2014) Wei Hu et al.   Annals of the New York Academy of Sciences

PCP-induced deficits in murine nest building activity: Employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia

(2014) Christian Spang Pedersen et al.   BEHAVIOURAL BRAIN RESEARCH

Glutaminase1 heterozygous mice show enhanced trace fear conditioning and Arc/Arg3.1 expression in hippocampus and cingulate cortex

(2014) Liran Hazan et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Behavioral phenotyping of Nestin-Cre mice: Implications for genetic mouse models of psychiatric disorders

(2014) Sebastian A. Giusti et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

(2014) M. I. Gross et al.   MOLECULAR CANCER THERAPEUTICS

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

Heterogeneous Cellular Distribution of Glutamate Dehydrogenase in Brain and in Non-neural Tissues

(2014) Cleanthe Spanaki et al.   NEUROCHEMICAL RESEARCH

Isolating Pathogenic Mechanisms Embedded within the Hippocampal Circuit through Regional Vulnerability

(2014) Scott A. Small   NEURON

Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition

(2014) A. I. Gilani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings

(2014) Eline M.P. Poels et al.   SCHIZOPHRENIA RESEARCH

Increased hippocampal CA1 cerebral blood volume in schizophrenia

(2014) Pratik Talati et al.   NeuroImage-Clinical

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

(2013) Usman A Khan et al.   NATURE NEUROSCIENCE

The contextual brain: implications for fear conditioning, extinction and psychopathology

(2013) Stephen Maren et al.   NATURE REVIEWS NEUROSCIENCE

Development of Mice with Brain-Specific Deletion of Floxed Glud1 (Glutamate Dehydrogenase 1) Using Cre Recombinase Driven by the Nestin Promoter

(2013) Melis Karaca et al.   NEUROCHEMICAL RESEARCH

Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver

(2013) Scott A. Schobel et al.   NEURON

Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia

(2013) Nina V. Kraguljac et al.   JAMA Psychiatry

Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia

(2012) Peter J Uhlhaas   CURRENT OPINION IN NEUROBIOLOGY

Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission

(2012) Francesca Frigerio et al.   JOURNAL OF NEUROCHEMISTRY

Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine

(2012) Nicholas E. Clifton et al.   PSYCHOPHARMACOLOGY

Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: Increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression

(2011) E.K. Michaelis et al.   NEUROCHEMISTRY INTERNATIONAL

Reversal learning and attentional set-shifting in mice

(2011) Gregory B. Bissonette et al.   NEUROPHARMACOLOGY

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

(2011) Bita Moghaddam et al.   NEUROPSYCHOPHARMACOLOGY

Hippocampal Volume Reduction in First-Episode and Chronic Schizophrenia

(2011) Fulvia Adriano et al.   NEUROSCIENTIST

The Hippocampal Formation in Schizophrenia

(2010) Carol A. Tamminga et al.   AMERICAN JOURNAL OF PSYCHIATRY

Alterations of NMDA receptor subunits NR1, NR2A and NR2B mRNA expression and their relationship to apoptosis following transient forebrain ischemia

(2010) Zhian Liu et al.   BRAIN RESEARCH

Highly accurate inverse consistent registration: A robust approach

(2010) Martin Reuter et al.   NEUROIMAGE

Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders

(2009) Scott A. Schobel et al.   ARCHIVES OF GENERAL PSYCHIATRY

Transgenic Expression of Glud1 (Glutamate Dehydrogenase 1) in Neurons: In Vivo Model of Enhanced Glutamate Release, Altered Synaptic Plasticity, and Selective Neuronal Vulnerability

(2009) X. Bao et al.   JOURNAL OF NEUROSCIENCE

Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to Schizophrenia

(2009) Inna Gaisler-Salomon et al.   NEUROPSYCHOPHARMACOLOGY

Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia

(2009) Daniel J. Lodge et al.   NEUROTOXICITY RESEARCH

Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

(2009) M. van den Buuse   SCHIZOPHRENIA BULLETIN

Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia

(2009) Scott A. Schobel et al.   SCHIZOPHRENIA RESEARCH

Loss of Glial Glutamate and Aspartate Transporter (Excitatory Amino Acid Transporter 1) Causes Locomotor Hyperactivity and Exaggerated Responses to Psychotomimetics: Rescue by Haloperidol and Metabotropic Glutamate 2/3 Agonist

(2008) Rose-Marie Karlsson et al.   BIOLOGICAL PSYCHIATRY

Deletion of Glutamate Dehydrogenase in ß-Cells Abolishes Part of the Insulin Secretory Response Not Required for Glucose Homeostasis

(2008) Stefania Carobbio et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry

(2008) S.J. Sawiak et al.   NEUROBIOLOGY OF DISEASE

Assessment of Glutamate Transporter GLAST (EAAT1)-Deficient Mice for Phenotypes Relevant to the Negative and Executive/Cognitive Symptoms of Schizophrenia

(2008) Rose-Marie Karlsson et al.   NEUROPSYCHOPHARMACOLOGY

Spike timing-dependent plasticity: a learning rule for dendritic integration in rat CA1 pyramidal neurons

(2007) Emilie Campanac et al.   JOURNAL OF PHYSIOLOGY-LONDON